Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
July 31, 2026 -2.895M
April 30, 2026 -1.845M
January 31, 2026 -2.144M
October 31, 2025 -2.038M
July 31, 2025 -3.066M
April 30, 2025 -0.7976M
January 31, 2025 -0.7331M
October 31, 2024 -1.647M
July 31, 2024 -1.331M
April 30, 2024 -1.162M
January 31, 2024 -0.7644M
October 31, 2023 -0.0064M
July 31, 2023 -0.4144M
April 30, 2023 -1.587M
January 31, 2023 -2.490M
October 31, 2022 -2.547M
July 31, 2022 -8.016M
April 30, 2022 -1.409M
January 31, 2022 -4.053M
October 31, 2021 -1.583M
July 31, 2021 -0.785M
April 30, 2021 -0.5789M
January 31, 2021 -0.5395M
October 31, 2020 0.3429M
July 31, 2020 0.2988M
Date Value
April 30, 2020 0.3992M
January 31, 2020 -0.0396M
October 31, 2019 -1.186M
July 31, 2019 -0.1833M
April 30, 2019 -0.6627M
January 31, 2019 -0.4315M
October 31, 2018 -1.194M
July 31, 2018 -0.1186M
April 30, 2018 -0.6182M
January 31, 2018 -0.3372M
October 31, 2017 -0.8157M
July 31, 2017 -0.9065M
April 30, 2017 -0.6154M
January 31, 2017
June 30, 2016
March 31, 2016
December 31, 2015 -0.0003M
September 30, 2015 -0.0016M
June 30, 2015 0.0018M
March 31, 2015 -0.0027M
December 31, 2014 0.044M
September 30, 2014 -0.0478M
June 30, 2014 0.0039M
March 31, 2014 -0.0319M
December 31, 2013 -0.1796M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Repligen Corp. 32.77M
Bio-Techne Corp. 95.42M
BioLife Solutions, Inc. 6.348M
Maravai Lifesciences Holdings, Inc. 3.992M
MaxCyte, Inc. -4.661M